High Tech Pharm Co., Ltd. (KOSDAQ: 106190)

High Tech Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,538	3,483	7,880	11,275	1,038	3,109
Short-Term Investments	-	-	-	-	-	7,222
Trading Asset Securities	-	1,882	-	1,363	-	-
Cash & Short-Term Investments	7,538	5,365	7,880	12,637	1,038	10,331
Cash Growth	27.02%	-31.92%	-37.64%	1117.51%	-89.95%	160.54%
Accounts Receivable	21,760	24,443	28,476	9,413	19,564	17,435
Other Receivables	26.19	40.1	78.47	58.39	112.9	117.07
Receivables	21,786	24,483	28,555	9,472	19,677	17,552
Inventory	34,406	25,498	14,676	17,708	18,632	9,884
Prepaid Expenses	1,358	1,191	885.83	545.12	1,078	896.26
Other Current Assets	52.91	33.78	43.53	126.73	51.48	361.21
Total Current Assets	65,141	56,571	52,040	40,488	40,477	39,024
Property, Plant & Equipment	73,624	75,001	74,934	80,544	85,205	89,918
Long-Term Investments	2,465	2,076	2,198	1,768	2,468	1,718
Long-Term Deferred Tax Assets	461.77	508.51	1,920	-	-	571.2
Other Long-Term Assets	623.46	901.23	1,110	136.16	297.29	493.38
Total Assets	142,316	135,058	132,202	122,937	128,446	131,725
Accounts Payable	6,296	8,692	13,130	10,451	16,824	17,017
Accrued Expenses	1,049	1,203	633.1	608.08	820.82	700.69
Short-Term Debt	11,946	11,447	10,000	10,000	5,000	5,000
Current Portion of Long-Term Debt	-	-	6,337	-	-	-
Current Portion of Leases	21.61	26.85	23.71	2.2	-	-
Current Income Taxes Payable	1,907	174.79	214.38	-	-	-
Current Unearned Revenue	-	-	178.69	570	570	570
Other Current Liabilities	1,491	1,241	1,222	1,072	3,718	2,266
Total Current Liabilities	22,710	22,785	31,738	22,703	26,933	25,554
Long-Term Debt	5,000	5,000	-	5,928	5,440	5,789
Long-Term Leases	16.85	25.78	63.55	47.89	41.17	21.85
Other Long-Term Liabilities	642.78	252.56	461.27	225.66	225.66	651.73
Total Liabilities	28,369	28,064	32,263	29,052	33,302	33,141
Common Stock	5,317	3,544	3,544	3,544	3,544	3,544
Additional Paid-In Capital	23,290	25,068	25,068	25,068	25,068	25,068
Retained Earnings	85,346	78,382	71,327	65,273	66,532	69,972
Comprensive Income & Other	0	0	0	0	-	-
Shareholders' Equity	113,946	106,994	99,939	93,885	95,144	98,584
Total Liabilities & Equity	142,316	135,058	132,202	122,937	128,446	131,725
Total Debt	16,984	16,500	16,424	15,978	10,481	10,811
Net Cash (Debt)	-9,446	-11,135	-8,543	-3,340	-9,443	-479.85
Net Cash Per Share	-1334.93	-1570.78	-803.00	-314.39	-888.78	-45.13
Filing Date Shares Outstanding	10.64	7.09	10.63	10.63	10.63	10.63
Total Common Shares Outstanding	10.64	7.09	10.63	10.63	10.63	10.63
Working Capital	42,431	33,786	20,302	17,786	13,544	13,470
Book Value Per Share	10710.12	15093.47	9398.78	8829.44	8947.82	9271.36
Tangible Book Value	113,946	106,994	99,939	93,885	95,144	98,584
Tangible Book Value Per Share	10710.12	15093.47	9398.78	8829.44	8947.82	9271.36
Land	7,933	7,933	7,880	7,832	7,669	7,498
Buildings	53,979	53,974	52,056	52,671	52,135	51,930
Machinery	45,019	44,953	43,826	43,765	43,531	43,221
Construction In Progress	3,368	2,326	554	408.55	476.55	468.5

Source: S&P Capital IQ. Standard template. Financial Sources.